A competing risks model with binary time varying covariates for estimation of breast cancer risks in BRCA1 families
暂无分享,去创建一个
E. John | I. Andrulis | L. Briollais | M. Daly | M. Terry | Yun-Hee Choi | J. Hopper | Hae Jung | S. Buys
[1] Jacques Simard,et al. Sequence kernel association test for survival outcomes in the presence of a non-susceptible fraction. , 2020, Biostatistics.
[2] H. Jacqmin-Gadda,et al. Joint nested frailty models for clustered recurrent and terminal events: An application to colonoscopy screening visits and colorectal cancer risks in Lynch Syndrome families , 2020, Statistical methods in medical research.
[3] W. Chung,et al. Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk , 2018, Journal of the National Cancer Institute.
[4] J. Horrocks,et al. Exponential decay for binary time‐varying covariates in Cox models , 2018, Statistics in medicine.
[5] W. Chung,et al. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers , 2017, JAMA.
[6] W. Chung,et al. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers , 2017, Journal of the National Cancer Institute.
[7] Aung Ko Win,et al. Modeling of successive cancer risks in Lynch syndrome families in the presence of competing risks using copulas , 2017, Biometrics.
[8] A. Green,et al. Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer. , 2015, Surgical oncology.
[9] M. Pollán,et al. Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: A systematic review and meta-analysis. , 2014, Breast.
[10] G. Parmigiani,et al. Calibrated predictions for multivariate competing risks models , 2014, Lifetime data analysis.
[11] R. Kay. The Analysis of Survival Data , 2012 .
[12] Malka Gorfine,et al. Frailty‐Based Competing Risks Model for Multivariate Survival Data , 2011, Biometrics.
[13] G. Feldman,et al. Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2 , 2010, Genetics in Medicine.
[14] L. Briollais,et al. Estimating Disease Risk Associated with Mutated Genes in Family-Based Designs , 2008, Human Heredity.
[15] M. Gorfine,et al. On robustness of marginal regression coefficient estimates and hazard functions in multivariate survival analysis of family data when the frailty distribution is mis‐specified , 2007, Statistics in medicine.
[16] Giovanni Parmigiani,et al. Meta-analysis of BRCA1 and BRCA2 penetrance. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] Norman Boyd,et al. The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer , 2004, Breast Cancer Research.
[18] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data: Kalbfleisch/The Statistical , 2002 .
[19] Johann Sölkner,et al. Frailty Models in Survival Analysis , 1996 .
[20] R Crouchley,et al. A comparison of frailty models for multivariate survival data. , 1995, Statistics in medicine.
[21] M. Schumacher,et al. The impact of heterogeneity on the comparison of survival times. , 1987, Statistics in medicine.
[22] John D. Kalbfleisch,et al. Misspecified proportional hazard models , 1986 .
[23] V T Farewell,et al. The analysis of failure times in the presence of competing risks. , 1978, Biometrics.
[24] Practice Bulletin No 182: Hereditary Breast and Ovarian Cancer Syndrome. , 2017, Obstetrics and gynecology.
[25] A. Yashin,et al. Genetic analysis of durations: Correlated frailty model applied to survival of Danish twins , 1995, Genetic epidemiology.
[26] John A. Nelder,et al. A Simplex Method for Function Minimization , 1965, Comput. J..